Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Adrenaline in Inflammatory Response in Type 1 Diabetes
NCT05990933Completed
- Start
- Dec 2023
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of epinephrine (2 arms). Primary endpoint: Monocyte count at 1 hour. Started Dec 2023; status: completed.
02
Drugs
epinephrine
Beyond the preview
Go deeper on NCT05990933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990933.